193 related articles for article (PubMed ID: 30210007)
1. Amarogentin as Topical Anticancer and Anti-Infective Potential: Scope of Lipid Based Vesicular in its Effective Delivery.
Patel K; Kumar V; Verma A; Rahman M; Patel DK
Recent Pat Antiinfect Drug Discov; 2019; 14(1):7-15. PubMed ID: 30210007
[TBL] [Abstract][Full Text] [Related]
2. Phytochemical investigation of crude methanol extracts of different species of Swertia from Nepal.
Khanal S; Shakya N; Thapa K; Pant DR
BMC Res Notes; 2015 Dec; 8():821. PubMed ID: 26708007
[TBL] [Abstract][Full Text] [Related]
3. The bitter barricading of prostaglandin biosynthesis pathway: understanding the molecular mechanism of selective cyclooxygenase-2 inhibition by amarogentin, a secoiridoid glycoside from Swertia chirayita.
Shukla S; Bafna K; Sundar D; Thorat SS
PLoS One; 2014; 9(6):e90637. PubMed ID: 24603686
[TBL] [Abstract][Full Text] [Related]
4. Contents of therapeutic metabolites in Swertia chirayita correlate with the expression profiles of multiple genes in corresponding biosynthesis pathways.
Padhan JK; Kumar V; Sood H; Singh TR; Chauhan RS
Phytochemistry; 2015 Aug; 116():38-47. PubMed ID: 26028519
[TBL] [Abstract][Full Text] [Related]
5. Detection of intermediates through high-resolution mass spectrometry for constructing biosynthetic pathways for major chemical constituents in a medicinally important herb, Swertia chirayita.
Kumar V; Sood H; Chauhan RS
Nat Prod Res; 2015; 29(15):1449-55. PubMed ID: 25622657
[TBL] [Abstract][Full Text] [Related]
6. Swertia chirayita: A comprehensive review on traditional uses, phytochemistry, quality assessment and pharmacology.
Swati K; Bhatt V; Sendri N; Bhatt P; Bhandari P
J Ethnopharmacol; 2023 Jan; 300():115714. PubMed ID: 36113678
[TBL] [Abstract][Full Text] [Related]
7. Highlighting the anti-carcinogenic potential of an ayurvedic medicinal plant, Swertia Chirata.
Saha P; Das S
Asian Pac J Cancer Prev; 2010; 11(6):1445-9. PubMed ID: 21338178
[TBL] [Abstract][Full Text] [Related]
8. Assessment of systemic interaction between Swertia chirata extract and its Bioactive constituents in rabbits.
Suryawanshi S; Asthana RK; Gupta RC
Phytother Res; 2009 Jul; 23(7):1036-8. PubMed ID: 19140153
[TBL] [Abstract][Full Text] [Related]
9. Phenolic-linked biochemical rationale for the anti-diabetic properties of Swertia chirayita (Roxb. ex Flem.) Karst.
Phoboo S; Pinto Mda S; Barbosa AC; Sarkar D; Bhowmik PC; Jha PK; Shetty K
Phytother Res; 2013 Feb; 27(2):227-35. PubMed ID: 22523004
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the anticarcinogenic activity of Swertia chirata Buch.Ham, an Indian medicinal plant, on DMBA-induced mouse skin carcinogenesis model.
Saha P; Mandal S; Das A; Das PC; Das S
Phytother Res; 2004 May; 18(5):373-8. PubMed ID: 15173996
[TBL] [Abstract][Full Text] [Related]
11. Swertia chirata: A Comprehensive Review with Recent Advances.
Jauhari N; Bharadvaja N; Sharma N
Curr Pharm Biotechnol; 2017; 18(9):730-739. PubMed ID: 29076426
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography/tandem mass spectrometric study and analysis of xanthone and secoiridoid glycoside composition of Swertia chirata, a potent antidiabetic.
Suryawanshi S; Mehrotra N; Asthana RK; Gupta RC
Rapid Commun Mass Spectrom; 2006; 20(24):3761-8. PubMed ID: 17120271
[TBL] [Abstract][Full Text] [Related]
13. Protective Effects of Amarogentin against Carbon Tetrachloride-Induced Liver Fibrosis in Mice.
Zhang Y; Zhao H; Li H; Cao W; Wang F; Zhang T; Wang SW
Molecules; 2017 May; 22(5):. PubMed ID: 28481234
[TBL] [Abstract][Full Text] [Related]
14. Optimization of harvest and extraction factors by full factorial design for the improved yield of C-glucosyl xanthone mangiferin from Swertia chirata.
Kaur P; Gupta RC; Dey A; Malik T; Pandey DK
Sci Rep; 2021 Aug; 11(1):16346. PubMed ID: 34381094
[TBL] [Abstract][Full Text] [Related]
15. A Review of Swertia chirayita (Gentianaceae) as a Traditional Medicinal Plant.
Kumar V; Van Staden J
Front Pharmacol; 2015; 6():308. PubMed ID: 26793105
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms.
Medda S; Mukhopadhyay S; Basu MK
J Antimicrob Chemother; 1999 Dec; 44(6):791-4. PubMed ID: 10590280
[TBL] [Abstract][Full Text] [Related]
17. Amarogentin regulates self renewal pathways to restrict liver carcinogenesis in experimental mouse model.
Sur S; Pal D; Banerjee K; Mandal S; Das A; Roy A; Panda CK
Mol Carcinog; 2016 Jul; 55(7):1138-49. PubMed ID: 26154024
[TBL] [Abstract][Full Text] [Related]
18. Phytochemistry and Pharmacological Activities of the Genus Swertia (Gentianaceae): A Review.
Li J; Zhao YL; Huang HY; Wang YZ
Am J Chin Med; 2017; 45(4):667-736. PubMed ID: 28490237
[TBL] [Abstract][Full Text] [Related]
19. Production of amarogentin in root cultures of Swertia chirata.
Keil M; Härtle B; Guillaume A; Psiorz M
Planta Med; 2000 Jun; 66(5):452-7. PubMed ID: 10909267
[TBL] [Abstract][Full Text] [Related]
20. Prevention of liver carcinogenesis by amarogentin through modulation of G1/S cell cycle check point and induction of apoptosis.
Pal D; Sur S; Mandal S; Das A; Roy A; Das S; Panda CK
Carcinogenesis; 2012 Dec; 33(12):2424-31. PubMed ID: 22948180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
